Mindfulness Meditation

Sponsor
Roswell Park Cancer Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT05098002
Collaborator
(none)
100
1
1
12.1
8.3

Study Details

Study Description

Brief Summary

To offer Roswell Park patients and caregivers a variety of options to reduce their stress and improve their psychological well-being amidst the difficulty of cancer

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness program
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Mindfulness Meditation
Actual Study Start Date :
Oct 29, 2021
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Oct 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindful based stress classes

6 week mindfulness program

Behavioral: Mindfulness program
6 week class designed to improve psychological well-being

Outcome Measures

Primary Outcome Measures

  1. Feasibility - Enrollment rates [6 weeks]

    Number of participants enrolled in virtual classes vs in person classes

Secondary Outcome Measures

  1. Acceptability [6 weeks]

    Percentage of participants who choose in person classes vs. virtual classess

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being over 18 years old

  • Cancer survivor or a caregiver of cancer patient/survivor.

Exclusion Criteria:
  • Unwilling or unable to complete the assessment in English.

  • Are unwilling or unable to follow protocol requirements.

  • Have any condition which in the Investigator's opinion deems the subject an unsuitable candidate to participate in this study including (based on criteria from the

Mindfulness-based stress reduction (MBSR) authorized curriculum guide):
  1. Drug addiction (or recent recovery)

  2. Bereavement (recent loss)

  3. Mental health inpatient (recently discharged)

  4. Current depression or other major psychiatric diagnoses (including suicidality or suicidal ideation) that would interfere with participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Roswell Park Comprehensive Cancer Center Buffalo New York United States 14263

Sponsors and Collaborators

  • Roswell Park Cancer Institute

Investigators

  • Principal Investigator: Elizabeth Bouchard, MD, Roswell Park Comprehensive Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT05098002
Other Study ID Numbers:
  • I 1946021
First Posted:
Oct 28, 2021
Last Update Posted:
Aug 4, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 4, 2022